Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] iron-sulfur protein 1, mitochondrial (NDUFS1) is the largest subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), located on the inner mitochondrial membrane. It plays a critical role in the electron transport chain by facilitating the transfer of electrons from NADH to ubiquinone, which is coupled to proton translocation across the membrane to drive ATP synthesis. NDUFS1 contains multiple iron-sulfur clusters (such as N1b, N4, and N5) that are essential for this electron transfer process.
Mutations in the NDUFS1 gene are a primary cause of mitochondrial complex I deficiency, leading to severe metabolic and neurodegenerative disorders such as Leigh syndrome, leukoencephalopathy, and cardiomyopathy. In oncology, NDUFS1 is implicated in tumor cell survival, cancer stem cell stemness, and immune cell infiltration, making it an attractive therapeutic target. Pharmacological agents targeting NDUFS1 or the larger complex I include biguanides like metformin and phenformin, natural products like agrimol B and phloretin, and classic inhibitors like rotenone. Inhibition of NDUFS1 disrupts mitochondrial respiration, reduces ATP production, and triggers the accumulation of cytotoxic reactive oxygen species (ROS), which can induce apoptosis or autophagy arrest in cancer cells.
Inhibition of mitochondrial complex I electron transport, leading to reduction of ATP synthesis, accumulation of reactive oxygen species (ROS), and induction of apoptosis or cytotoxic autophagy arrest.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein 1, mitochondrial (NDUFS1).